Not logged in
Share
Save
Share
Save
Share
Save
Share
Save
Share
SavePaclitaxel plus cetuximab for the treatment of recurrent and/or metastatic head and neck cancer after first-line checkpoint inhibitor failure: Primary analysis from the pace ace trial
Fuereder, T.; Klinghammer, K.; Hahn, D. A.; Gruenberger, B.; Melchardt, T.; Greil, R.; Kocher, F.; Gamerith, G.; Wagner, C.; Berchtold, L.; Burian, M.; Strobl, A.
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save
Share
Save